The Director, Clinical Scientist will lead cross-functional study teams for Phase 2 and 3 respiratory trials, overseeing protocol development, data analysis, and regulatory documentation. They will also manage medical monitoring activities, site engagement, and ensure trial execution aligns with regulatory requirements and timelines.
The Senior Director, Medical Monitor will provide medical oversight for late-stage respiratory clinical trials, ensuring patient safety and protocol compliance. They will also collaborate cross-functionally to interpret clinical data and contribute to regulatory filings and study reports.
The Vice President will lead late-stage Immunology and Inflammation programs, shaping integrated development strategies and guiding cross-functional teams through regulatory submission. They are responsible for building a high-performing team of physicians and scientists while ensuring clinical excellence and alignment with corporate objectives.
